Cardiorenal risk in type 2 diabetes: a case-based discussion
15 Oct 2024
Keynote Theatre
This is a promotional symposium sponsored and organised by AstraZeneca, intended for GB HCPs only.
Through the lens of a hypothetical patient, Jenny, let's look beyond glucose management in people with type 2 diabetes and address their cardiorenal risk.
AstraZeneca medicines will be mentioned during this presentation.
GB-58815, DOP: Sept 2024
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}
.jpg/fit-in/1280x9999/filters:no_upscale()){kind=logo}
.png/fit-in/1280x9999/filters:no_upscale())
)
){kind=logo}
){kind=logo}
